Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
12,05 USD | -3,29 % | -17,58 % | -19,29 % |
10/04 | NOVOCURE LIMITED : recomendación de compra de Piper Sandler | ZM |
05/04 | NovoCure afirma que nuevos datos muestran los posibles efectos terapéuticos de TTFields en el cáncer de páncreas | MT |
Resumen de negocios
Número de empleados: 1 453
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Tumor Treating Fields
100,0
%
| 538 | 100,0 % | 509 | 100,0 % | -5,30 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
68,7
%
| 407 | 75,7 % | 350 | 68,7 % | -14,05 % |
Germany
11,8
%
| 46 | 8,6 % | 60 | 11,8 % | +30,55 % |
Others
8,7
%
| 0 | 0,0 % | 44 | 8,7 % | - |
Japan
6,2
%
| 33 | 6,1 % | 32 | 6,2 % | -3,40 % |
Greater China
4,6
%
| 21 | 4,0 % | 23 | 4,6 % | +8,87 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01/01/02 |
Ashley Cordova
DFI | Director of Finance/CFO | 45 | 01/06/14 |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nicolas Leupin
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/01 |
Chief Operating Officer | 66 | 05/01/12 | |
Ingrid Goldberg
IRC | Investor Relations Contact | - | 01/07/21 |
Barak Ben Arye
LAW | General Counsel | 48 | 01/01/18 |
Corporate Officer/Principal | - | - | |
Uri Weinberg
PRN | Corporate Officer/Principal | 46 | 01/03/08 |
Michael Puri
HRO | Human Resources Officer | 55 | 01/09/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bill Doyle
CHM | Chairman | 61 | 01/01/04 |
Kin Yip Leung
BRD | Director/Board Member | 62 | 05/08/11 |
David Hung
BRD | Director/Board Member | 66 | 31/05/18 |
Timothy Scannell
BRD | Director/Board Member | 60 | 05/02/21 |
Jeryl Hilleman
BRD | Director/Board Member | 66 | 25/07/18 |
Tony Vernon
BRD | Director/Board Member | 68 | 01/01/06 |
Asaf Danziger
CEO | Chief Executive Officer | 56 | 01/01/02 |
Martin Madden
BRD | Director/Board Member | 64 | 10/05/17 |
Kristin Stafford
BRD | Director/Board Member | 42 | 28/03/23 |
Allyson Ocean
BRD | Director/Board Member | 52 | 23/02/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 107 093 432 | 105 308 013 ( 98,33 %) | 0 | 98,33 % |
Información de la empresa
NovoCure Ltd.
No. 4 The Forum Grenville Street
JE2 4UF, St. Helier
+44 15 3475 6700
http://www.novocure.comSector
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-19,29 % | 1296,66 M | |
+71,86 % | 12,28 mil M | |
-17,04 % | 8076,68 M | |
+16,56 % | 7229 M | |
-6,64 % | 5292,46 M | |
+4,25 % | 4928,37 M | |
+17,19 % | 4185,72 M | |
-21,30 % | 4126,48 M | |
-40,39 % | 2243,07 M | |
-5,20 % | 2001,52 M |
- Bolsa de valores
- Acciones
- Acción NVCR
- Empresa NovoCure Limited